维普中文期刊产品整合服务
36篇 您的检索式:作者名="JOOSSENS S"
    题名 作者 年代 出处 被引量
1Toll-like receptor-I, -2, and-6 polymorphisms influence disesse extension in inflammatory bowel disease显示文摘Pierk M Joossens S Van Steen K 2006Inflarrun Bowel Dis2006,12,1:1
2Serological markers for prediction of response to anti-tumor necrosis factor treatment in Crohn's disease显示文摘Esters N Vermeire S Joossens S 2002Am J Gastroenterol2002,97,6:1
3Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohns disease 显示文摘Vermeire S Joossens M Verbeke K 2012Gastroenterology2012,142,51:1
4The value of serologic markers in indeterminate colitis: A prospective follow-up study显示文摘Sofie Joossens Walter Reinisch Séverine Vermeire Boualem Sendid Daniel Poulain Marc Peeters Karel Geboes Xavier Bossuyt Peggy Vandewalle Georg Oberhuber Harald Vogelsang Paul Rutgeerts Jean-Frédéric Colombel 2002Gastroenterology2002,,:1
5Toll-Like receptor-1,-2,and -6 polymorphisms influence disease extension in inflammatory bowel diseases显示文摘Pierik M Joossens S Steen KV 2006Inflamm Bowel Dis2006,12,1:1
6The value of serologic markers in indeterminate colitis: a prospective follow-up study 显示文摘JOOSSENS S REINISCH W VERMEIRE S 2002Gastroenterology2002,122,5:1
7Anti-α-enolase antibodies in patients with inflammatory bowel disease 显示文摘Vermeulen N Arijs I Joossens S 2008Clin Chem2008,54,3:1
8Diagnostic value of anti- Saccharorayces cerevisiae and antineutrophil cytoplasmic autoantibod- ies in inflammatory bowel disease 显示文摘Peeters M Joossens S Vermeire S 2001Am J Gastroenterol2001,96,3:1
9Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae(ASCA) in patients with Crohn' s disease显示文摘Joossens S Pierik M Rector A 2006Gut2006,55,5:1
10The value of serologic markers in indeterminate colitis:a prospective follow-up study显示文摘Joossens S Reinisch W Vermeire S 2002Gastroenterology2002,122,5:1
11The value of serologic markers in indeterminate colitis: a prospective follow-up study 显示文摘Joossens S Reinisch W Vermeire S 2002Gastroenterology2002,122,5:1
12Sal922 Pilot study on thesafety and efficacy of faecal microbiota transplantation in refractoryCrohn's disease 显示文摘Vermeire S Joossens M Verbeke K 2012Gastroenterology2012,142,5:1
13Role of antineutrophIL cytoplasmic autoantibodies in inflammatory bowel disease显示文摘Peeters M Joossens S 2001Am J Gastroenterol2001,96,3:1
14The value of serologic markers in indeterminate colitis: a prospective follow-up study显示文摘Joossens S Reninisch W Vermeier S 2002Gastroenterology2002,122,:1
15Detec- tion of antisynthetic mannoside antibodies(ASigmaMA) reveals het- erogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction 显示文摘Vandewalle-E1 Khoury P Colombel JF Joossens S 2008Am J Gastroenterol2008,103,4:1
16Serological markers for pre- diction of response to anti-tumor necrosis factor treatment in Crohn's disease显示文摘Esters N Vermeire S Joossens S 2002Am J Gastroenterol2002,97,6:1
17Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn' s disease 显示文摘Vermeire S Joossens M Verbeke K 2012Gastroenterology2012,142,:1
18Diagnostic value of anti-Saccharo- myces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflam- matory bowel disease显示文摘Peeters M Joossens S Vermeire S 2001Am J Gastroenterol2001,96,3:1
19Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn ' s disease 显示文摘Vermeire S Joossens M Verbeke K 2012Gastroenterology2012,142,:1
20Anti-α-enolase antibodies in patients with inflammatory bowel disease 显示文摘Vermeulen N Arijs I Joossens S 2008Clin Chem2008,54,3:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费